LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Kodu・Aktsiate loetelu・LivaNova PLC

LivaNova PLC

Suletud

58.68 0.81

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

57.47

Max

58.86

Põhinäitajad
By Trading Economics
Sissetulek	354M 27M
Müük	36M 353M
P/E Sektori keskmine	31.716 35.733
Aktsiakasum	0.88
Kasumimarginaal	7.705
Töötajad	2,900
EBITDA	340M 54M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+35.96% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	29. okt 2025

Turustatistika
By TradingEconomics
Turukapital	746M 3.1B
Eelmine avamishind	57.87
Eelmine sulgemishind	58.68

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

36.34 / N/A Toetus ja vastupanu

LivaNova PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. sept 2025, 23:37 UTC

Kuumad aktsiad

Stocks to Watch: Oracle, Wearable Devices, GameStop

9. sept 2025, 20:41 UTC

Tulu

Oracle's Backlog Surges With Major Customer Deals in 1Q

9. sept 2025, 20:30 UTC

Tulu

GameStop 2Q Sales, Profit Rise

9. sept 2025, 23:19 UTC

Market Talk

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9. sept 2025, 21:35 UTC

Tulu

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 21:32 UTC

Tulu

Oracle's Backlog Swells With Big Customer Deals -- Update

9. sept 2025, 21:02 UTC

Omandamised, ülevõtmised, äriostud

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. sept 2025, 20:33 UTC

Tulu

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9. sept 2025, 20:26 UTC

Tulu

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 20:23 UTC

Tulu

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 20:12 UTC

Tulu

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9. sept 2025, 20:10 UTC

Tulu

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9. sept 2025, 20:10 UTC

Tulu

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9. sept 2025, 20:09 UTC

Tulu

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9. sept 2025, 20:09 UTC

Tulu

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9. sept 2025, 20:08 UTC

Tulu

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9. sept 2025, 20:08 UTC

Tulu

Oracle 1Q Operating Income Was $4.3 B >ORCL

9. sept 2025, 20:08 UTC

Tulu

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9. sept 2025, 20:08 UTC

Tulu

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9. sept 2025, 20:07 UTC

Tulu

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9. sept 2025, 20:06 UTC

Tulu

Oracle 1Q Software Revenue $5.72B >ORCL

9. sept 2025, 20:06 UTC

Tulu

Synopsys 3Q Adj EPS $3.39 >SNPS

9. sept 2025, 20:06 UTC

Tulu

Oracle 1Q Cloud Revenue $7.19B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Rev $14.93B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q EPS $1.01 >ORCL

9. sept 2025, 20:05 UTC

Tulu

Synopsys 3Q EPS $1.50 >SNPS

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Services Revenue $1.35B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Adj EPS $1.47 >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Hardware Revenue $670M >ORCL

Võrdlus sarnastega

Hinnamuutus

LivaNova PLC Prognoos

Hinnasiht

By TipRanks

35.96% tõus

12 kuu keskmine prognoos

Keskmine 79.29 USD 35.96%

Kõrge 168 USD

Madal 58 USD

Põhineb 7 Wall Streeti analüütiku instrumendi LivaNova PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi LivaNova PLC aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

36.34 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.